SAM
RARE icon

Smartleaf Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Smartleaf Asset Management’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$110K Buy
5,723
+3,234
+130% +$72.8K ﹤0.01% 1059
2025
Q4 		$56.7K Buy
2,489
+751
+43% +$24.7K ﹤0.01% 1484
2025
Q3 		$52.8K Buy
1,738
+1,169
+205% +$35.1K ﹤0.01% 1375
2025
Q2 		$20.8K Sell
569
-158
-22% -$5.7K ﹤0.01% 1537
2025
Q1 		$27.5K Buy
727
+44
+6% +$1.83K ﹤0.01% 1446
2024
Q4 		$28.9K Buy
683
+493
+259% +$24.5K ﹤0.01% 1452
2024
Q3 		$10.3K Buy
190
+74
+64% +$3.77K ﹤0.01% 1738
2024
Q2 		$4.8K Buy
116
+106
+1,060% +$4.53K ﹤0.01% 1828
2024
Q1 		$468 Buy
+10
New +$472 ﹤0.01% 1751

Other funds holding RARE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return